Rocket Pharmaceuticals Inc
RCKT3.364USD
-0.166-4.71%
Market hours （ET）Quotes delayed by 15 min
363.98MMarket Cap
LossP/E TTM
Rocket Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.73
6.65%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.729, with a year-on-year change of 6.65%.
What is the net income of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its net income was -258.75M, with a year-on-year change of -5.35%.
What is the net margin of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 4.02%, with a year-on-year change of 7.80%.
What is the Return on Equity (ROE) of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -54.14%, with a year-on-year change of -8.27%.
What is the Return on Assets (ROA) of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -47.30%, with a year-on-year change of -7.68%.
What is the operating profit of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -273.20M, with a year-on-year change of -6.53%.
What are the current assets of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its current assets were 378.18M, with a year-on-year change of -0.01%.
What are the total assets of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its total assets of Rocket Pharmaceuticals Inc were 527.70M, with a year-on-year change of -6.82%.
What are the total liabilities of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Rocket Pharmaceuticals Inc were 64.47M, with a year-on-year change of -12.61%.
What is the total equity of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its total equity of Rocket Pharmaceuticals Inc was 463.23M, with a year-on-year change of -5.96%.
What is the net operating income of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Rocket Pharmaceuticals Inc was -258.75M, with a year-on-year change of -5.35%.
What is the net investment of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its net investment of Rocket Pharmaceuticals Inc was 131.71M, with a year-on-year change of 234.30%.
What is the net financing of Rocket Pharmaceuticals Inc?
According to Rocket Pharmaceuticals Inc's FY2024 earnings report, its net financing of Rocket Pharmaceuticals Inc was 185.74M, with a year-on-year change of -10.87%.
